Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-27

Clinical Trial Update: Effects of 5HTP on the Injured Human Spinal Cord [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 clinical trial evaluating the effects of 5-HTP on spinal cord injury; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-HTP (5-hydroxytryptophan)

Snippet

Sponsor: University of Alberta | Conditions: Spinal Cord Injuries | Phase 2, Phase 3 | Status: RECRUITING